Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 30 K30 K30 K30 K30 K 120 K Research & development ————— — Operating income -110.86 K-112.71 K-169.08 K-164.52 K-268.32 K -714.63 K Non-Operating Income, Total 741.14 K744.21 K752.04 K452.49 K158.03 K 2.11 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 741.14 K744.21 K752.04 K452.49 K158.03 K 2.11 M Unusual income/expense ————— — Pretax income 630.28 K631.5 K582.96 K287.97 K-110.29 K 1.39 M Equity in earnings ————— — Taxes ————— — Non-controlling/minority interest ————— — After tax other income/expense ————-46.1 K — Net income before discontinued operations 630.28 K631.5 K582.96 K287.97 K-110.29 K 1.39 M Discontinued operations ————— — Net income 630.28 K631.5 K582.96 K287.97 K-110.29 K 1.39 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 107.42 K110.66 K168.49 K164.4 K110.29 K 553.84 K Basic earnings per share (Basic EPS) -0.01-0.01-0.02-0.03-0.07 -0.13 Diluted earnings per share (Diluted EPS) -0.01-0.01-0.02-0.03-0.07 -0.13 Average basic shares outstanding 2 M2 M2 M2 M2 M — Diluted shares outstanding 2 M2 M2 M2 M2 M — EBITDA -68.88 K-63.46 K-131.31 K—— — EBIT -107.42 K-110.66 K-168.49 K-164.4 K-318.31 K -761.85 K Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 38.54 K47.2 K37.17 K—— —